Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Hohenfellner

Showing results (121-130 of 136) with videos related to

Pageof 14
Sort By:
Molecular Imaging and Biology|August 23, 2022
Detecting and Locating the Site of Local Relapse Using <sup>18</sup>F-PSMA-1007 Imaging After Primary Treatment of 135 Prostate Cancer Patients-Potential Impact on PSMA-Guided Radiation TherapyS A Koerber, R C Kroener, K Dendl, et al.
British Journal of Cancer|October 31, 2007
Expression of inhibitor of apoptosis protein Livin in renal cell carcinoma and non-tumorous adult kidneyN Wagener, I Crnković-Mertens, C Vetter, et al.
Prostate Cancer and Prostatic Diseases|May 18, 2016
Further reduction of disqualification rates by additional MRI-targeted biopsy with transperineal saturation biopsy compared with standard 12-core systematic biopsies for the selection of prostate cancer patients for active surveillanceJ P Radtke, T H Kuru, D Bonekamp, et al.
British Journal of Cancer|January 10, 2013
Endogenous BTG2 expression stimulates migration of bladder cancer cells and correlates with poor clinical prognosis for bladder cancer patientsN Wagener, J Bulkescher, S Macher-Goeppinger, et al.
Prostate Cancer and Prostatic Diseases|June 17, 2015
Improved detection of anterior fibromuscular stroma and transition zone prostate cancer using biparametric and multiparametric MRI with MRI-targeted biopsy and MRI-US fusion guidanceJ P Radtke, S Boxler, T H Kuru, et al.
European Radiology|June 27, 2018
Twelve-month prostate volume reduction after MRI-guided transurethral ultrasound ablation of the prostateDavid Bonekamp, M B Wolf, M C Roethke, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 18, 2025
Open versus robotic-assisted partial nephrectomy in patients with intermediate/high-complexity kidney tumours: final results of the randomised, controlled, open-label, multicentre trial OpeRaM-O Grimm, J Bedke, J Nyarangi-Dix, et al.
Der Urologe. Ausg. A|October 6, 2010
[Patients with bladder cancer in clinical stage T2 : survival benefit of downstaging in comparison to patients with confirmed muscle invasion in cystectomy specimens]M May, H-M Fritsche, S Brookman-May, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|March 8, 2013
Prediction of outcome in patients with urothelial carcinoma of the bladder following radical cystectomy using artificial neural networksA Buchner, M May, M Burger, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|March 31, 2012
External validation of disease-free survival at 2 or 3 years as a surrogate and new primary endpoint for patients undergoing radical cystectomy for urothelial carcinoma of the bladderP Nuhn, M May, H-M Fritsche, et al.
Pageof 14

Showing results (121-130 of 136) with videos related to

Sort By:
Pageof 14
Molecular Imaging and Biology|August 23, 2022
Detecting and Locating the Site of Local Relapse Using <sup>18</sup>F-PSMA-1007 Imaging After Primary Treatment of 135 Prostate Cancer Patients-Potential Impact on PSMA-Guided Radiation TherapyS A Koerber, R C Kroener, K Dendl, et al.
British Journal of Cancer|October 31, 2007
Expression of inhibitor of apoptosis protein Livin in renal cell carcinoma and non-tumorous adult kidneyN Wagener, I Crnković-Mertens, C Vetter, et al.
Prostate Cancer and Prostatic Diseases|May 18, 2016
Further reduction of disqualification rates by additional MRI-targeted biopsy with transperineal saturation biopsy compared with standard 12-core systematic biopsies for the selection of prostate cancer patients for active surveillanceJ P Radtke, T H Kuru, D Bonekamp, et al.
British Journal of Cancer|January 10, 2013
Endogenous BTG2 expression stimulates migration of bladder cancer cells and correlates with poor clinical prognosis for bladder cancer patientsN Wagener, J Bulkescher, S Macher-Goeppinger, et al.
Prostate Cancer and Prostatic Diseases|June 17, 2015
Improved detection of anterior fibromuscular stroma and transition zone prostate cancer using biparametric and multiparametric MRI with MRI-targeted biopsy and MRI-US fusion guidanceJ P Radtke, S Boxler, T H Kuru, et al.
European Radiology|June 27, 2018
Twelve-month prostate volume reduction after MRI-guided transurethral ultrasound ablation of the prostateDavid Bonekamp, M B Wolf, M C Roethke, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 18, 2025
Open versus robotic-assisted partial nephrectomy in patients with intermediate/high-complexity kidney tumours: final results of the randomised, controlled, open-label, multicentre trial OpeRaM-O Grimm, J Bedke, J Nyarangi-Dix, et al.
Der Urologe. Ausg. A|October 6, 2010
[Patients with bladder cancer in clinical stage T2 : survival benefit of downstaging in comparison to patients with confirmed muscle invasion in cystectomy specimens]M May, H-M Fritsche, S Brookman-May, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|March 8, 2013
Prediction of outcome in patients with urothelial carcinoma of the bladder following radical cystectomy using artificial neural networksA Buchner, M May, M Burger, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|March 31, 2012
External validation of disease-free survival at 2 or 3 years as a surrogate and new primary endpoint for patients undergoing radical cystectomy for urothelial carcinoma of the bladderP Nuhn, M May, H-M Fritsche, et al.
Pageof 14